Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Pharmacogenet Genomics. 2019 Feb;29(2):39–47. doi: 10.1097/FPC.0000000000000363

Table 3b.

Prediction of reduced activity haplotype (H3) by *41 in four populations

Haplotype Frequency in the population (%)
EUR ASN AFR AMR
rs16947 without rs5758550 (H3) 11.6 6.3 23.9 10.5
rs16947 without rs5758550 marked by *41 8.6 2.8 1 7.5
% rs16947 without rs5758550(H3) marked by *41 74 44 4 71